Department of Environmental Health Sciences, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA; Center for Dietary Supplements Research, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA; USP Botanical Dietary Supplements Admission Evaluation and Labeling Expert Committee, United States Pharmacopeial Convention (USP), Rockville, MD, USA.
Office of Dietary Supplement Programs, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, USA.
Regul Toxicol Pharmacol. 2024 Nov;153:105708. doi: 10.1016/j.yrtph.2024.105708. Epub 2024 Sep 19.
Botanical supplements and herbal products are widely used by consumers for various purported health benefits, and their popularity is increasing. Some of these natural products can have adverse effects on liver function and/or interact with prescription and over-the-counter (OTC) medications. Ensuring the safety of these readily available products is a crucial public health concern; however, not all regulatory authorities require premarket safety review and/or testing. To address and discuss these and other emerging needs related to botanical safety, a symposium was held at the Society of Toxicology Annual Meeting in Salt Lake City (UT) on March 11, 2024. The symposium addressed the latest research on botanical-induced liver toxicity and botanical-drug interactions, including new approach methods to screen for toxicity, challenges in assessing the safety of botanicals, and relating human adverse events to specific products. The presentations and robust panel discussion between the speakers and audience highlighted the need for further research and collaboration to improve the safety of botanical supplements and herbal products, with the ultimate goal of protecting consumer health. Although utility of many of the modern tools presented in the symposium requires further study, the synergistic efforts of diverse experts hold promise for effective prediction and evaluation of botanical-induced hepatotoxicity and botanical-drug interaction potential.
植物补充剂和草药产品广泛被消费者用于各种所谓的健康益处,其受欢迎程度正在上升。其中一些天然产品可能对肝功能有不良影响,或者与处方药和非处方药 (OTC) 药物相互作用。确保这些现成产品的安全性是一个至关重要的公共卫生问题;然而,并非所有监管机构都要求进行上市前的安全性审查和/或测试。为了解决和讨论这些以及与植物安全性相关的其他新出现的需求,在盐湖城(犹他州)举行的毒理学学会年会上举办了一次专题研讨会。该研讨会讨论了植物引起的肝毒性和植物-药物相互作用的最新研究,包括用于毒性筛查的新方法、评估植物安全性的挑战,以及将人类不良反应与特定产品联系起来。演讲者和观众之间的演讲和热烈的小组讨论强调了进一步研究和合作的必要性,以提高植物补充剂和草药产品的安全性,最终目标是保护消费者健康。尽管研讨会中提出的许多现代工具的实用性需要进一步研究,但不同专家的协同努力有望有效预测和评估植物引起的肝毒性和植物-药物相互作用的潜力。